326 related articles for article (PubMed ID: 19835554)
21. Identification of Transporters Involved in Beraprost Sodium Transport In Vitro.
Oshida K; Shimamura M; Seya K; Ando A; Miyamoto Y
Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):117-128. PubMed ID: 26961540
[TBL] [Abstract][Full Text] [Related]
22. Expression of drug transporters and drug metabolizing enzymes in the bladder urothelium in man and affinity of the bladder spasmolytic trospium chloride to transporters likely involved in its pharmacokinetics.
Bexten M; Oswald S; Grube M; Jia J; Graf T; Zimmermann U; Rodewald K; Zolk O; Schwantes U; Siegmund W; Keiser M
Mol Pharm; 2015 Jan; 12(1):171-8. PubMed ID: 25466967
[TBL] [Abstract][Full Text] [Related]
23. Nonionic surfactants modulate the transport activity of ATP-binding cassette (ABC) transporters and solute carriers (SLC): Relevance to oral drug absorption.
Al-Ali AAA; Nielsen RB; Steffansen B; Holm R; Nielsen CU
Int J Pharm; 2019 Jul; 566():410-433. PubMed ID: 31125713
[TBL] [Abstract][Full Text] [Related]
24. Overview: Role of Drug Transporters in Drug Disposition and Its Clinical Significance.
Liu X
Adv Exp Med Biol; 2019; 1141():1-12. PubMed ID: 31571163
[TBL] [Abstract][Full Text] [Related]
25. Pharmacogenetics of membrane transporters: an update on current approaches.
Sissung TM; Baum CE; Kirkland CT; Gao R; Gardner ER; Figg WD
Mol Biotechnol; 2010 Feb; 44(2):152-67. PubMed ID: 19950006
[TBL] [Abstract][Full Text] [Related]
26. Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium.
Yee SW; Brackman DJ; Ennis EA; Sugiyama Y; Kamdem LK; Blanchard R; Galetin A; Zhang L; Giacomini KM
Clin Pharmacol Ther; 2018 Nov; 104(5):803-817. PubMed ID: 29679469
[TBL] [Abstract][Full Text] [Related]
27. Circadian regulation of transporter expression and implications for drug disposition.
Pácha J; Balounová K; Soták M
Expert Opin Drug Metab Toxicol; 2021 Apr; 17(4):425-439. PubMed ID: 33353445
[No Abstract] [Full Text] [Related]
28. Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia.
Megías-Vericat JE; Martínez-Cuadrón D; Solana-Altabella A; Poveda JL; Montesinos P
Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456712
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenetics of drug transporters in the enterohepatic circulation.
Stieger B; Meier PJ
Pharmacogenomics; 2011 May; 12(5):611-31. PubMed ID: 21619426
[TBL] [Abstract][Full Text] [Related]
30. Pharmacogenomic importance of ABCG2.
Cusatis G; Sparreboom A
Pharmacogenomics; 2008 Aug; 9(8):1005-9. PubMed ID: 18681776
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters (BCRP/MXR/ABCP/ABCG2).
Meyer zu Schwabedissen HE; Kroemer HK
Handb Exp Pharmacol; 2011; (201):325-71. PubMed ID: 21103975
[TBL] [Abstract][Full Text] [Related]
32. Pharmacogenomics of ABC transporters and its role in cancer chemotherapy.
Sparreboom A; Danesi R; Ando Y; Chan J; Figg WD
Drug Resist Updat; 2003 Apr; 6(2):71-84. PubMed ID: 12729805
[TBL] [Abstract][Full Text] [Related]
33. Pharmacogenetics of ABC and SLC transporters in metastatic colorectal cancer patients receiving first-line FOLFIRI treatment.
De Mattia E; Toffoli G; Polesel J; D'Andrea M; Corona G; Zagonel V; Buonadonna A; Dreussi E; Cecchin E
Pharmacogenet Genomics; 2013 Oct; 23(10):549-57. PubMed ID: 24018773
[TBL] [Abstract][Full Text] [Related]
34. Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs.
Ieiri I; Higuchi S; Sugiyama Y
Expert Opin Drug Metab Toxicol; 2009 Jul; 5(7):703-29. PubMed ID: 19442037
[TBL] [Abstract][Full Text] [Related]
35. Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox.
Özvegy-Laczka C; Ungvári O; Bakos É
Biochem Pharmacol; 2023 Mar; 209():115448. PubMed ID: 36758706
[TBL] [Abstract][Full Text] [Related]
36. Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.
Lai Y; Varma M; Feng B; Stephens JC; Kimoto E; El-Kattan A; Ichikawa K; Kikkawa H; Ono C; Suzuki A; Suzuki M; Yamamoto Y; Tremaine L
Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):723-43. PubMed ID: 22509796
[TBL] [Abstract][Full Text] [Related]
37. In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney.
Kusuhara H; Sugiyama Y
Drug Metab Pharmacokinet; 2009; 24(1):37-52. PubMed ID: 19252335
[TBL] [Abstract][Full Text] [Related]
38. Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters.
Sasabe H; Shimokawa Y; Shibata M; Hashizume K; Hamasako Y; Ohzone Y; Kashiyama E; Umehara K
Antimicrob Agents Chemother; 2016 Jun; 60(6):3497-508. PubMed ID: 27021329
[TBL] [Abstract][Full Text] [Related]
39. Single nucleotide polymorphisms in ABCC2 and ABCB1 genes and their clinical impact in physiology and drug response.
Wada M
Cancer Lett; 2006 Mar; 234(1):40-50. PubMed ID: 16377077
[TBL] [Abstract][Full Text] [Related]
40. Characterization of ABC transporters in human skin.
Osman-Ponchet H; Boulai A; Kouidhi M; Sevin K; Alriquet M; Gaborit A; Bertino B; Comby P; Ruty B
Drug Metabol Drug Interact; 2014; 29(2):91-100. PubMed ID: 24558228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
